Microbix Biosystems Inc.

TSX:MBX.TO

0.315 (CAD) • At close October 30, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) CAD.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997
Revenue 16.51519.07618.59310.52513.41212.51110.1869.5178.8748.3977.5756.676.2286.4636.0824.9944.0493.6444.3774.0672.8472.8072.9891.8571.63.12.7
Cost of Revenue 9.0337.9517.5495.8646.8657.1415.3734.5373.0343.8853.743.9153.2442.7292.5182.4792.1161.7511.6751.4911.0240.8350.950.5770.60.60.5
Gross Profit 7.48111.12511.0444.6616.5475.3694.8124.985.844.5123.8342.7552.9853.7353.5652.5151.9331.8932.7012.5771.8231.9712.0391.27912.52.2
Gross Profit Ratio 0.4530.5830.5940.4430.4880.4290.4720.5230.6580.5370.5060.4130.4790.5780.5860.5040.4770.5190.6170.6340.640.7020.6820.6890.6250.8060.815
Reseach & Development Expenses 2.0471.7991.0331.0131.0421.090.9950.4941.2770.6910.4460.560.530.4940.7031.1940.9850.8860.5730.9670.6680.4440.3470.2293.81.60.9
General & Administrative Expenses 6.5325.0014.2173.543.7443.6143.9283.132.8691.8471.7892.2492.2432.9632.89000000000000
Selling & Marketing Expenses 1.4781.5540.8580.6330.6510.5560.4650.5170.6020.6570.8941.5221.3921.4721.462000000000000
SG&A 8.016.5555.0754.1724.3954.1714.3933.6473.4712.5042.6833.7713.6354.4344.3514.4553.0152.6821.8111.5091.4271.2611.1991.2371.52.61.2
Other Expenses 0.1610.160.099000-0.274000-0.04100.4610.4570.8790.3560.2730.2430.1670.1540.1540.1610.180.2070.30.30.2
Operating Expenses 10.2188.5156.2075.1855.4385.265.3874.1414.7483.1953.0884.3314.6265.3855.9346.0054.2743.8112.552.632.2491.8651.7261.6735.64.52.3
Operating Income -2.7362.6924.837-0.5251.11-0.743-1.50.1480.3490.4760.168-1.576-1.641-1.651-2.369-3.49-2.341-1.9180.151-0.053-0.4260.1060.313-0.394-4.6-2-0.1
Operating Income Ratio -0.1660.1410.26-0.050.083-0.059-0.1470.0160.0390.0570.022-0.236-0.264-0.255-0.389-0.699-0.578-0.5260.035-0.013-0.150.0380.105-0.212-2.875-0.645-0.037
Total Other Income Expenses Net 3.079-0.827-1.603-4.135-1.066-7.879-2.731-0.691-0.742-0.8410.131-1.06-0.973000-0.3710.0380.150.150.1130.0190.0310.0200.10.1
Income Before Tax -0.0391.8663.233-4.6590.044-8.622-4.230.1480.3490.4760.168-2.637-2.614000-2.712-2.0920.2140.097-0.3140.1250.344-0.3740-1.90
Income Before Tax Ratio -0.0020.0980.174-0.4430.003-0.689-0.4150.0160.0390.0570.022-0.395-0.42000-0.67-0.5740.0490.024-0.110.0450.115-0.2010-0.6130
Income Tax Expense 0.8390.0771.6031.5680.012-7.027-0.45-0.6-0.2650.3070.16700.0040.8880.760.17800.2120.0880.0830.050.0550.1030.0770.10.20.1
Net Income -0.0391.7891.63-6.2280.032-8.622-3.780.7480.6140.1690.001-2.637-2.614-2.538-2.485-3.668-2.712-2.0920.1260.014-0.3640.070.241-0.45-4.7-2.1-0.1
Net Income Ratio -0.0020.0940.088-0.5920.002-0.689-0.3710.0790.0690.020-0.395-0.42-0.393-0.408-0.735-0.67-0.5740.0290.004-0.1280.0250.081-0.243-2.938-0.677-0.037
EPS -00.0130.014-0.0590-0.09-0.0450.0090.0080.0020-0.043-0.048-0.052-0.054-0.08-0.07-0.060.0040-0.010.0020.01-0.013-0.14-0.06-0.003
EPS Diluted -00.0130.012-0.0590-0.09-0.0450.0090.0070.0020-0.043-0.048-0.052-0.054-0.08-0.07-0.060.0040-0.010.0020.01-0.013-0.14-0.06-0.003
EBITDA -1.1223.7295.6590.1651.6790.799-0.3381.2531.5131.731.175-1.145-1.177-1.194-1.314-3.134-2.068-1.6750.3180.101-0.2720.2670.493-0.186-4.3-1.70.1
EBITDA Ratio -0.0680.1950.3040.0160.1250.064-0.0330.1320.170.2060.155-0.172-0.189-0.185-0.216-0.628-0.511-0.460.0730.025-0.0960.0950.165-0.1-2.688-0.5480.037